Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.

One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment ...

One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment ...

Adding encorafenib and cetuximab to chemotherapy backbone also prolonged overall survival ...

A new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy drug, and atezolizumab, an immune checkpoint inhibitor, helped patients with metastatic colorectal cancer, ...

Human epidermal growth factor receptor 2 (HER2) is a transmembrane tyrosine kinase receptor whose amplification or overexpression drives tumour cell proliferation and survival. In metastatic ...

Christopher Lieu, MD, discusses improved outcomes with targeted therapy and the importance of early, personalized cancer care ...

Colon cancer diagnosis involves colonoscopy, imaging, and blood tests, with staging guiding treatment decisions. Stage 1 treatment typically involves surgery, while stage 2 may include chemotherapy ...

"ASCO 2026: Interim data released for upcoming BRAF and RAS mCRC therapies" was originally created and published by Clinical ...

Metastatic colorectal cancer (mCRC) remains a leading cause of cancer mortality, driving continual refinement of first-line treatment strategies. Progress in molecular profiling has enabled ...

Time Toxicity in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine Plus Cisplatin With or Without Durvalumab Most patients with metastatic colorectal cancer (CRC) have microsatellite ...